Is Korro Bio, Inc. (KRRO) overvalued? · rev $2.3M
Korro Bio, Inc. (KRRO) is a biotechnology company listed on US.
This page asks whether Korro Bio, Inc. (KRRO) looks expensive on cached numbers — not a short thesis.
Latest reported KRRO revenue for 2024-12-31 was $2.3M. Net income was -$83.6M. KRRO currently screens at market cap $159.8M.
KRRO currently screens at market cap $159.8M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next KRRO 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the KRRO stock page for the full model, not this heading.
Not investment advice.